Pulse Biosciences PLSE
NASDAQ PLSE
$49.83 -0.09 (-0.18%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pulse Biosciences (PLSE) Current Deferred Revenue (2021 - 2023)

Updated

Pulse Biosciences' Current Deferred Revenue came in at $4,000 for Q1 2023, down 75.0% from $16,000 a year earlier.

Analysis

Pulse Biosciences (PLSE) Current Deferred Revenue (2021 - 2023) Analysis & Trends

At the end of FY2021, Pulse Biosciences' Current Deferred Revenue was $16,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Pulse Biosciences 3.53 Bn 3.53 Bn 161,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 4,000.00
Sep 30, 2022 38,000.00
Jun 30, 2022 32,000.00
Mar 31, 2022 16,000.00
Dec 31, 2021 16,000.00
Sep 30, 2021 7,000.00
API Access

Pulse Biosciences Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PLSE&period=max&api_key=YOUR_API_KEY